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Development and Evaluation of a Novel, Semiautomated Clostridium
difficile Typing Platform
Lars F. Westblade,a Robin R. Chamberland,a Duncan MacCannell,d Rachel Collins,a Erik R. Dubberke,b W. Michael Dunne, Jr.,a*
Carey-Ann D. Burnhama,c

We describe a novel, semiautomated Clostridium difficile typing platform that is based on PCR-ribotyping in conjunction with a
semiautomated molecular typing system. The platform is reproducible with minimal intra- or interassay variability. This
method exhibited a discriminatory index of 0.954 and is therefore comparable to more arduous typing systems, such as pulsedfield gel electrophoresis.

C

lostridium difficile, the etiological agent of C. difficile infection
(CDI), is an important cause of both hospital- and community-acquired infectious diarrhea (1, 2). The emergence of hypervirulent C. difficile isolates and in particular the NAP1/BI/027 isolate has altered the epidemiology of C. difficile infections in many
health care institutions, resulting in increased severity and duration of disease, with concomitant increases to the length and cost
of hospitalization (1). Therefore, typing methods that can dis-

criminate NAP1/BI/027 and other emerging hypervirulent C. difficile isolates may be important for understanding the transmission dynamics of the organism. In addition, it has recently been
demonstrated that the analytical sensitivity and specificity of C.
difficile diagnostic assays may be dependent on the C. difficile
strain type (3). In addition, recent reports suggest that the relapse
rate following treatment with certain novel antianaerobic and C.
difficile-specific antimicrobials could correlate with C. difficile
strain type (4, 5); thus, an appreciation of the isolate type may play
a role in patient management in the future. As such, C. difficile
typing may have the potential to improve the management of CDI
beyond clinical surveillance, especially in the hospital setting, and
it may be important for clinical laboratorians and infection control specialists to have a baseline understanding of the different C.
difficile isolates circulating in their institutions.
Pulsed-field gel electrophoresis (PFGE) is the principal reference method employed for C. difficile typing in North America
(6). While PFGE affords acceptable discriminatory power (6), it
does suffer from some important limitations, in particular the
labor intensity, technical expertise, turnaround time, and necessity for control strains to be processed alongside isolates of epidemiological interest. In Europe, the predominant method for C.
difficile typing is PCR-ribotyping, which involves the PCR amplification of the intergenic space region between the 16S and 23S
rRNA genes (7, 8, 9). For many years, epidemiologic studies for C.
difficile have relied on PFGE and PCR-ribotyping to determine
strain relatedness; multiple-locus variable-number tandem-repeat analysis (MLVA) for C. difficile typing has also been described
for recent studies (6, 10, 11, 12). Although this method does appear to be reproducible and discriminatory, it requires access to a

Received 1 October 2012 Returned for modification 24 October 2012
Accepted 19 November 2012

FIG 1 Intra- and interassay variability of the PCR-ribotyping/DiversiLab C.
difficile typing platform. Dendrogram illustrating the gel electrophoresis profiles of 24 PCR-ribotyping reactions obtained for eight different C. difficile
isolates (isolates A to H). Samples loaded onto the first Agilent chip are indicated by lightface capitalized letters, while PCR-ribotyping reactions loaded
onto the second Agilent chip are indicated by letters in bold italics. The percent
SI is indicated by the bar below the dendrogram; isolates with a SI of ⱖ95% are
considered very related or identical.
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FIG 2 Evaluation of the performance of the PCR-ribotyping/DiversiLab C.
difficile typing platform at the local level. The dendrogram illustrates the electrophoresis profiles of a collection of 74 C. difficile isolates obtained from both
the CDC and our institution. Isolates obtained from the CDC are indicated by
their PFGE pulsotype and are in bold italics, while patient isolates are indicated
numerically. The collection was differentiated into 17 clusters with 15 unrelated strains, yielding a discrimination index of 0.954. The percent SI is indicated by the bar below the dendrogram; ⱖ95% are very related or identical.

622

jcm.asm.org

Journal of Clinical Microbiology

Downloaded from http://jcm.asm.org/ on March 8, 2014 by Washington University in St. Louis

genetic analyzer/DNA sequencer, which is cost prohibitive to
many laboratories.
The objective of this study was to develop and validate a semiautomated PCR-ribotyping platform that would further reduce
labor intensity, allow analysis of isolates in real time, provide objective downstream data analysis, maintain discriminatory power,
and be a feasible option for routine benchtop typing of C. difficile
isolates in a clinical setting. As such, we evaluated the performance
of PCR-ribotyping in conjunction with the DiversiLab system
(bioMérieux, Durham, NC) and the 2100 Bioanalyzer instrument
(Agilent; Santa Clara, CA, USA) for fragment separation and
PCR-ribotype band pattern analysis. A significant advantage of
this platform is that all resultant banding patterns are banked
electronically so that they may be recalled and compared retrospectively.
(This work was presented in part at the 111th General Meeting
of the American Society for Microbiology, New Orleans, LA, May
2011.)
Initially, we evaluated the intra- and interassay variability of
the PCR-ribotyping/DiversiLab platform. Therefore, in a blinded
experiment, prior to PCR-ribotype amplification, genomic DNA
isolated from eight C. difficile isolates (labeled A to H) previously
characterized as having unique PFGE types (6) was distributed
into 24 tubes such that each tube contained DNA from only one
isolate (C. difficile DNA was isolated using the BiOStic bacteremia
DNA kit [MO BIO; Carlsbad, CA]). To perform the PCR-ribotyping reaction, a 25-l PCR mixture that included 100 ng of C.
difficile DNA, a Ready-To-Go randomly amplified polymorphic
DNA (RAPD) analysis bead (GE Healthcare Life Sciences; Piscataway, NJ), and primers complementary to the 3= end of the 16S
rRNA gene (5=-CTGGGGTGAAGTCGTAACAAGG-3=) and the
5= end of the 23S ribosomal gene (5=-GCGCCCTTTGTAGCTTG
ACC-3=) at a final concentration of 0.5 M was assembled (13).
The amplification conditions were 35 cycles of denaturation at
94°C for 1 min, annealing at 55°C for 1 min, and extension at 72°C
for 1 min. The PCR products were loaded into two different
DiversiLab DNA chips (bioMérieux; Durham, NC) according to
the manufacturer’s specifications and resolved using the 2100 Bioanalyzer instrument. The resultant banding patterns were analyzed using the DiversiLab Bacterial Barcodes software program,
which uses curve-based Pearson coefficients for pairwise similarity scores (14). The data were organized into a dendrogram, and a
similarity index (SI) for each pair was calculated (Fig. 1). By applying a SI of ⱖ95%, the PCR-ribotype band patterns were separated into eight clusters, with each cluster corresponding to an
isolate. Upon examination of the resultant dendrograms, it is clear
that independent PCR-ribotype patterns obtained for each C. difficile isolate cluster together when loaded onto either the same or
different DNA chips and that this is both discriminatory and reproducible. Taken together, these data support our assessment of
limited intra- and interassay variability.
To assess the effect of culture duration and subculture fre-
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TABLE 1 Agreement between PFGE and the semiautomated C. difficile
PCR-ribotyping platform
Patient
isolate

Pulsotype inferred from
PCR-ribotyping

Pulsotype determined
by PFGE

15
16
17
20
23
28
35
39
47

NAP6
NAP1
NAP6
NAP1
NAP1
NAP1
NAP1
NAP2
NAP4

NAP6
NAP1
NAP6
NAP1
NAP1
NAP1 related
NAP1
NAP2
NAP4

institution prior to administration of expensive C. difficile-specific
antimicrobials and to monitor diagnostic assay performance. After C. difficile is recovered in culture, the hands-on time per isolate
to complete this typing method is approximately 1 h. After the
initial investment of acquiring the hardware and software for this
method, the cost of analyzing a single isolate is approximately $50.
However, up to 12 samples can be analyzed in a single chip or run,
and if 12 isolates are run in a batch, the cost per isolate is reduced
to approximately $35. With the ability to bank banding patterns
and compare isolates in real-time to previously typed isolates, it
will be relatively easy for institutions to create their own C. difficile
strain typing database.
Therefore, we believe that the rapid, facile, and discriminatory
novel, semiautomated PCR-ribotyping platform described herein
will be favorably useful to epidemiologists, clinicians, and laboratory medicine professionals involved in managing CDIs.
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quency on the reproducibility of the PCR-ribotype band patterns,
a C. difficile isolate (ATCC 9689) was incubated anaerobically at
35°C on cycloserine-cefoxitin-fructose agar (CCFA) plates for 2, 5
or 14 days or consecutively passaged onto CCFA plates one, three
or five times. Subsequently, the cells were collected, their DNA
was extracted, and PCR-ribotyping was performed. The PCR-ribotype band patterns were analyzed using the DiversiLab Bacterial
Barcodes software program, and dendrograms to illustrate strain
relatedness were generated. From inspection of the PCR product
electrophoresis profiles and the associated dendrograms, it was
found that PCR-ribotype patterns are not altered significantly in
response to either culture duration (SI ⬎ 98% across all conditions) or subculture frequency (SI ⬎ 99% across all conditions),
indicating that the semiautomated typing platform can tolerate
considerable variation in culture conditions; this has been demonstrated previously for other typing methods (15, 16).
In an effort to evaluate the performance of the semiautomated,
PCR-ribotyping platform at typing C. difficile isolates at the local
level, a collection of 50 C. difficile isolates cultured from the stools
of patients with a positive toxin A/B assay in our institution and, as
a calibrant, 24 C. difficile isolates whose PFGE pulsotypes had been
previously determined (6) was analyzed (Fig. 2). To ensure a
highly diverse calibrant collection, C. difficile isolates with the
NAP1, NAP2, NAP4, NAP6, and NAP12 PFGE pulsotypes and
isolates that did not map to previously characterized PFGE pulsotypes (UN for “unnamed” types) were included. The 74 isolates
were separated into 17 clusters, with 15 unrelated isolates yielding
a discrimination index (D) (17) of 0.954 with 95% confidence
intervals for D of 0.931 to 0.977 (18), which is in very close agreement with findings of previous studies evaluating the discriminatory power of different C. difficile typing methods (6, 9). However,
the discriminatory index of some of these prior studies could be
somewhat skewed, since NAP1 strains are typically in abundance
in contemporary epidemiological studies.
A requirement of molecular typing methods is an ability to
group related isolates and differentiate unrelated isolates. Our
method can do both, grouping the PCR-ribotyping patterns obtained for isolates with identical PFGE pulsotypes and differentiating the PCR-ribotyping patterns attained for isolates with different PFGE pulsotypes. In an effort to further validate the
discriminatory power of the semiautomated, PCR-ribotyping
platform, a collection of patient isolates whose PCR-ribotyping
patterns clustered with those obtained for isolates with known
PFGE pulsotypes (i.e., calibrant isolates) was analyzed using
PFGE. In all cases, the patient isolate yielded a PFGE pulsotype
very similar, if not identical, to that of the calibrant isolate it had
clustered with after PCR-ribotyping analysis (Table 1).
The novel, semiautomated C. difficile typing platform described here has some advantages over PFGE and other more intensive molecular typing methodologies; in particular, it is less
labor-intensive. Data analysis is automated, easy to perform, and
can be done within a matter of minutes, while ensuring a high
discriminatory power. In addition, the ability to bank isolate PCRribotype patterns for retrospective and prospective analysis is an
advancement in C. difficile typing and could facilitate the rapid,
streamlined examination of epidemiological trends.
At present, the primary utility of C. difficile typing is to assist
epidemiological studies; however, it is possible that real-time C.
difficile typing will become increasingly relevant in routine clinical
management to identify the predominant C. difficile isolates in an
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